The conference provides an unique scope involving a blend of science, technology and business. It brings together leading international scientists, engineers, top-level industrial management and business executives for discussions on the status of advanced materials, new technologies and industrial and business opportunities. The conference is truly multidisciplinary and global with participation of scientists, engineers, industrialists and business representatives. There were expected 350 national and International delegates, including Prof. Yury Gogotsi, Drexel University, USA. He was one of the keynote and plenary speakers at the conference.
The conference included general plenary talks, tutorials, invited lectures, contributed talks as well as poster sessions. An industrial exhibition was held and also 3-4 parallel sessions was organized to cover the conference topics.
The main conference objectives are:
To highlight advances and new findings in polymers and advanced materials and their impact on new technologies;To facilitate technology transfer and new business opportunities by bringing together representative from academia, research centers, industries and business;
To foster international collaborations and joint ventures;
To cooperate with the formation of the new generations of scientific and professionals committed to the scientific-technological innovation in the region;
To promote the growth of scientific and technical infrastructure in the field of polymers and advanced materials technologies.
|
|
|
|
|
Trustee Chair Professor of Materials Science and Engineering Director, A.J. Drexel Nanotechnology Institute Y.Gogotsi with researches during the excursion to the diamond mines. Pretoria/South Africa. 22 - 27 May 2011
|
||
|
|
|
|
|
|
|
|
MXenes potential applications include sensors, wound healing materials, and drug delivery systems. A recent study explored how different synthesis methods affect the safety and performance of MXenes. By comparing etching conditions and intercalation strategies, researchers discovered that fine-tuning the surface chemistry of MXenes plays a crucial role in improving biocompatibility. These results provide practical guidelines for developing safer MXenes and bring the field one step closer to real biomedical applications.
Exellent news, our joint patent application with Drexel University on highly porous MAX phase precursor for MXene synthesis published. Congratulations and thanks to all team involved!
Last Call! Have you submitted your abstract for IEEE NAP-2025 yet? Join us at the International Symposium on "The MXene Frontier: Transformative Nanomaterials Shaping the Future" – the largest MXene-focused conference in Europe this year! Final Submission Deadline: May 15, 2025. Don’t miss this exclusive opportunity to showcase your research and engage with world leaders in the MXene field!
We are excited to announce the publication of latest review article on MXenes in Healthcare. This comprehensive review explores the groundbreaking role of MXenes—an emerging class of 2D materials—in revolutionizing the fields of medical diagnostics and therapeutics. Read the full article here: https://doi.org/10.1039/D4NR04853A.
Congratulations and thank you to our collaborators from TU Wien and CEST for very interesting work and making it published! In this work, an upscalable electrochemical MXene synthesis is presented. Yields of up to 60% electrochemical MXene (EC-MXene) with no byproducts from a single exfoliation cycle are achieved.
Congratulations to all collaborators with this interesting joint work!
Thank you to our collaborators for the amazing joint work recently published in Graphene and 2D Nanomaterials about MXene–silk fibroin composite films aiming to develop materials with tunable electronic and thermal properties
Dr. Oleksiy Gogotsi, director of MRC and Carbon-Ukraine, innovative companies that are among the leaders on the world MXene market, visited 2024 MRS Fall Meeting & Exhibit. together with Dr. Maksym Pogorielov, Head of Advanced Biomaterials and Biophysics Laboratory, University of Latvia.
MRC and Carbon-Ukraine team visited the 3rd International MXene conference held at Drexel University on August 5-8, 2024. Conference brought together the best reserchers and leading experts on MXene field. 
Together with colleagues from the University of Latvia, MRC/Carbone Ukraine, Adam Mickiewicz University, University Clinic Essen, and others, we have developed a novel concept involving the binding of antibodies to MXenes. In our research, we utilized anti-CEACAM1 antibodies to develop targeted photo-thermal therapy for melanoma (in vitro), paving the way for future in vivo studies and clinical trials. For the first time, we demonstrate the feasibility of delivering MXenes specifically targeted to melanoma cells, enabling the effective ablation of cancer cells under near-infrared (NIR) light. This new technique opens up vast potential for the application of MXenes in cancer treatment, diagnostics, drug delivery, and many other medical purposes.
